Skip to main content

Edgemond James's Form 4 filing

United Therapeutics Corp (UTHR) · filed Jun 3, 2025

Accession no.
0001562180-25-004346
Filed
Jun 3, 2025
Trade date
Jun 2, 2025
Filing delay
1 day
Rule 10b5-1 plan
Checked

This filing lists 5 non-derivative transactions and 1 derivative transaction. Open-market sales total $3.91M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Edgemond JamesCIK 0001636178Officer (CFO AND TREASURER)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 2, 2025Common StockMOption exerciseAcquired+12,000$117.76+$1,413,12020,118Direct
Jun 2, 2025Common StockSSaleDisposed−2,603$325.54F3−$847,380.6217,515Direct
Jun 2, 2025Common StockSSaleDisposed−1,397$326.34F4−$455,896.9816,118Direct
Jun 2, 2025Common StockSSaleDisposed−5,347$325.59F3−$1,740,929.7310,771Direct
Jun 2, 2025Common StockSSaleDisposed−2,653$326.31F4−$865,700.438,118Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jun 2, 2025Common StockMOption exerciseDisposed−12,000$0.00$099,500Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F3

This transaction was executed in multiple trades at prices ranging from $325.00 to $325.98. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 2 transactions in Table I.

F4

This transaction was executed in multiple trades at prices ranging from $326.00 to $326.81. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 2 transactions in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)